Dietary Supplements for Erectile Dysfunction: Analysis of Marketed Products, Systematic Review, Meta-Analysis and Rational Use.
IIEF
botanical extract
dietary supplements
erectile dysfunction
nutraceuticals
sexual disorder
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
22 Aug 2023
22 Aug 2023
Historique:
received:
28
06
2023
revised:
17
08
2023
accepted:
18
08
2023
medline:
11
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
The use of nutraceutical products to enhance male sexual performance has a long history, especially with regard to the treatment of erectile dysfunction (ED). Alternative treatments for ED are becoming increasingly popular, with growing interest from consumers, as well as increased revenue for manufacturers. Dietary supplements (DSs), which are a mixture of active ingredients, are mainly sold online. In randomized controlled trials, the molecules contained in DSs have demonstrated varying degrees of effectiveness, or even have no evidence to support their use. However, none of the studies carried out provided sufficient evidence to consider these products a first-line therapy. Therefore, the combination of the various active ingredients, especially in relation to the daily dose, leaves doubts about the real effectiveness. In order to evaluate the potential efficacy of DS formulations, we analyzed the products marketed in Italy using a scoring approach. A systematic review of the literature was performed to evaluate the effect of DS and to detect the active ingredients able to improve erectile function-called effective ingredients (EIs)-and their minimal effective daily dose (mED). A metanalysis identified some nutraceuticals, such as Panax ginseng, Tribulus terrestris and L-arginine, that are able to improve male sexual function. Based on the scoring system, 2 (8%) supplements matched with the cluster of higher expected efficacy, 3 (12%) with the lower efficacy cluster and 20 (80%) matched with the criterion of no expected efficacy. DSs marketed in Italy are usually blends of many substances that are frequently employed at a negligible dose or without any evidence.
Identifiants
pubmed: 37686709
pii: nu15173677
doi: 10.3390/nu15173677
pmc: PMC10490034
pii:
doi:
Substances chimiques
Arginine
94ZLA3W45F
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Références
Food Chem Toxicol. 2017 Sep;107(Pt A):362-372
pubmed: 28698154
J Prev Med Hyg. 2022 Oct 17;63(2 Suppl 3):E239-E245
pubmed: 36479475
Drugs. 2018 Apr;78(6):643-673
pubmed: 29633089
Ayu. 2011 Jul;32(3):322-8
pubmed: 22529644
Int J Impot Res. 2013 Mar-Apr;25(2):45-50
pubmed: 23254461
Arab J Urol. 2021 Jun 11;19(3):323-339
pubmed: 34552783
Oxid Med Cell Longev. 2022 May 29;2022:1035441
pubmed: 35677108
Evid Based Complement Alternat Med. 2013;2013:571420
pubmed: 24371462
Asian J Androl. 2007 Mar;9(2):241-4
pubmed: 16855773
Lancet. 2013 Jan 12;381(9861):153-65
pubmed: 23040455
Evid Based Complement Alternat Med. 2012;2012:429268
pubmed: 23243445
World J Urol. 2018 Oct;36(10):1681-1689
pubmed: 29725807
Cell Prolif. 2019 Nov;52(6):e12696
pubmed: 31599060
Psychopharmacology (Berl). 2012 Oct;223(4):381-8
pubmed: 22552758
Actas Urol Esp. 2014 May;38(4):244-8
pubmed: 24630840
Sex Med Rev. 2020 Jul;8(3):431-442
pubmed: 32139335
JAMA. 2016 Nov 1;316(17):1838
pubmed: 27802547
Int J Impot Res. 1997 Sep;9(3):155-61
pubmed: 9315493
Eur Urol. 2021 Sep;80(3):333-357
pubmed: 34183196
J Endocrinol Invest. 2023 Jun;46(6):1241-1274
pubmed: 36698034
J Urol. 1987 Jun;137(6):1168-72
pubmed: 3295302
Plants (Basel). 2021 Apr 10;10(4):
pubmed: 33920217
BMC Fam Pract. 2020 Aug 16;21(1):166
pubmed: 32799804
Nutrients. 2021 Oct 11;13(10):
pubmed: 34684554
Cochrane Database Syst Rev. 2021 Apr 19;4:CD012654
pubmed: 33871063
Adv Nutr. 2021 Jun 1;12(3):744-765
pubmed: 33150931
Diabet Med. 2017 Sep;34(9):1185-1192
pubmed: 28722225
Bratisl Lek Listy. 2019;120(12):941-944
pubmed: 31855055
J Urol. 2002 Nov;168(5):2070-3
pubmed: 12394711
Circulation. 2006 Oct 17;114(16):1761-91
pubmed: 17015792
J Sex Med. 2019 Jun;16(6):843-852
pubmed: 31036522
Medicine (Baltimore). 2019 Sep;98(37):e17186
pubmed: 31517876
Int J Impot Res. 2021 Apr;33(3):311-317
pubmed: 32358510
Phytother Res. 2022 Nov;36(11):4115-4124
pubmed: 36017529
J Endocrinol Invest. 2022 May;45(5):941-961
pubmed: 34973154
J Ethnopharmacol. 2016 Feb 17;179:345-55
pubmed: 26727646
Urol Int. 1999;63(4):220-3
pubmed: 10743698
J Ethnopharmacol. 2019 May 10;235:392-405
pubmed: 30790614
JAMA Netw Open. 2021 Feb 1;4(2):e2036337
pubmed: 33599772
Urol Clin North Am. 2022 May;49(2):209-217
pubmed: 35428427
J Sex Marital Ther. 2003 May-Jun;29(3):207-13
pubmed: 12851125
Andrology. 2020 Sep;8(5):970-987
pubmed: 32026626
Lancet. 1987 Aug 22;2(8556):421-3
pubmed: 2887726
JAMA Netw Open. 2018 Oct 5;1(6):e183337
pubmed: 30646238
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008294
pubmed: 22336841
BJU Int. 1999 Feb;83(3):269-73
pubmed: 10233492
Urology. 1997 Mar;49(3):441-4
pubmed: 9123711
Maturitas. 2021 Mar;145:78-85
pubmed: 33541567
Cochrane Database Syst Rev. 2021 Jul 15;7:CD013656
pubmed: 34693990
Health Sci Rep. 2022 Jul 20;5(4):e741
pubmed: 35873404
J Diet Suppl. 2017 Nov 2;14(6):599-612
pubmed: 28471731
Maturitas. 2017 May;99:20-26
pubmed: 28364864
Asian J Androl. 2009 May;11(3):356-61
pubmed: 19234482
Front Endocrinol (Lausanne). 2022 Feb 04;12:824078
pubmed: 35185789
Urologia. 2019 May;86(2):74-78
pubmed: 30253697